August 14, 2026

Electrospinning in regenerative medicine

Electrospinning in regenerative medicine

Electrospun fibers open up a wide range of possibilities in regenerative medicine and for in vitro testing. A key factor in ensuring success is replicating the natural extracellular matrix (ECM) as closely as possible. Electrospun fibers play a significant role in this regard due to their nanofiber structure. In a recent review article, Julia Schütz, Ruben Daum, and Hanna Hartmann provide a detailed overview of methods for fiber production and functionalization, as well as various application examples.

To enable targeted cell-material interactions, the polymer fibers can also be biofunctionalized. This includes surface coating with ECM proteins to improve cell adhesion and interaction, as well as the integration and release of active substances for targeted stimulation, and, last but not least, the development of electrically conductive fibers.

In addition, the NMI researchers describe the development of hybrid fiber-hydrogel systems in which electrospun fiber fragments are integrated into hydrogels. This combination unites the biofunctional and mechanical properties of fibrillar scaffolds with the flexibility of hydrogels in terms of shape and size.

Paper: Schütz, J. et al., Functionalization of Electrospun Fibers and Hydrogel Integration: Tailoring Scaffolds for Tissue-Specific Regeneration. Regenerative Biomaterials.

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp